The validation of new CHD1L inhibitors as a therapeutic strategy for cancerBIOMEDICINE & PHARMACOTHERAPYIF7.52024-01-010OAAI
Selective Depletion of Complement-Binding Anti-HLA Antibodies Following BLyS Neutralization with Belimumab.TRANSPLANTATIONIF52014-07-011OAAI
Renal transplantation in patients with pretransplant donor-specific antibodies and negative flow cytometry crossmatchesAMERICAN JOURNAL OF TRANSPLANTATIONIF8.22008-03-011OA
未登录.png){kind=icon}
未登录
